Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
400KRW
9.76 BKRW
221.12 BKRW
4.96 M
About MEDY-TOX INC.
Sector
Industry
CEO
Hyun-Ho Jeong
Website
Headquarters
Cheongwon-gun
Employees (FY)
737
Founded
2000
ISIN
KR7086900008
FIGI
BBG000DQYSC5
Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and antitoxin therapeutics. The company was founded on May 2, 2000 and is headquartered in Cheongwon-gun, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 086900 is 135000 KRW — it has decreased by 4.32% in the past 24 hours. Watch MEDY-TOX INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEDY-TOX INC. stocks are traded under the ticker 086900.
086900 stock has risen by 3.61% compared to the previous week, the month change is a 4.17% rise, over the last year MEDY-TOX INC. has showed a 45.89% decrease.
We've gathered analysts' opinions on MEDY-TOX INC. future price: according to them, 086900 price has a max estimate of 180000.00 KRW and a min estimate of 170000.00 KRW. Watch 086900 chart and read a more detailed MEDY-TOX INC. stock forecast: see what analysts think of MEDY-TOX INC. and suggest that you do with its stocks.
086900 reached its all-time high on Jul 10, 2018 with the price of 700100 KRW, and its all-time low was 10300 KRW and was reached on Jan 16, 2009. View more price dynamics on 086900 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
086900 stock is 7.69% volatile and has beta coefficient of 1.02. Track MEDY-TOX INC. stock price on the chart and check out the list of the most volatile stocks — is MEDY-TOX INC. there?
Today MEDY-TOX INC. has the market capitalization of 873.05 B, it has increased by 1.10% over the last week.
Yes, you can track MEDY-TOX INC. financials in yearly and quarterly reports right on TradingView.
MEDY-TOX INC. is going to release the next earnings report on Aug 9, 2024. Keep track of upcoming events with our Earnings Calendar.
MEDY-TOX INC. revenue for the last quarter amounts to 54.60 B KRW despite the estimated figure of 59.65 B KRW. In the next quarter revenue is expected to reach 57.95 B KRW.
086900 net income for the last quarter is −1.47 B KRW, while the quarter before that showed −2.05 B KRW of net income which accounts for 28.25% change. Track more MEDY-TOX INC. financial stats to get the full picture.
As of May 29, 2024, the company has 737.00 employees. See our rating of the largest employees — is MEDY-TOX INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDY-TOX INC. EBITDA is 30.02 B KRW, and current EBITDA margin is 14.77%. See more stats in MEDY-TOX INC. financial statements.
Like other stocks, 086900 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDY-TOX INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDY-TOX INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDY-TOX INC. stock shows the sell signal. See more of MEDY-TOX INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.